{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:34:37Z","timestamp":1789097677043,"version":"build-2803163510"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Cushing\u2019s syndrome (CS) resulting from endogenous hypercortisolism can be sporadic or can occur in the context of familial disease because of pituitary or extra-pituitary neuroendocrine tumors. Multiple endocrine neoplasia type 1 (MEN1) is unique among familial endocrine tumor syndromes because hypercortisolism in this context can result from pituitary, adrenal, or thymic neuroendocrine tumors and can therefore reflect either ACTH-dependent or ACTH-independent pathophysiologies. The prominent expressions of MEN1 include primary hyperparathyroidism, tumors of the anterior pituitary, gastroenteropancreatic neuroendocrine tumors, and bronchial carcinoid tumors along with several common non-endocrine manifestations such as cutaneous angiofibromas and leiomyomas. Pituitary tumors are present in about 40% of MEN1 patients, and up to 10% of such tumors secrete ACTH that can result in Cushing\u2019s disease. Adrenocortical neoplasms occur frequently in MEN1. Although such adrenal tumors are mostly clinically silent, this category can include benign or malignant tumors causing hypercortisolism and CS. Ectopic tumoral ACTH secretion has also been observed in MEN1, almost exclusively originating from thymic neuroendocrine tumors. The range of clinical presentations, etiologies, and diagnostic challenges of CS in MEN1 are reviewed herein with an emphasis on the medical literature since 1997, when the MEN1 gene was identified.<\/jats:p>","DOI":"10.3389\/fendo.2023.1183297","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T10:24:43Z","timestamp":1687256683000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Expressions of Cushing\u2019s syndrome in multiple endocrine neoplasia type 1"],"prefix":"10.3389","volume":"14","author":[{"given":"William F.","family":"Simonds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing\u2019s syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"B2","first-page":"475","article-title":"Multiple endocrine neoplasia type 1","volume-title":"The genetic basis of human cancer","author":"Marx","year":"2002"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verges","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-002-6492-4","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1","volume":"26","author":"Langer","year":"2002","journal-title":"World J Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.1427","article-title":"Multiple endocrine neoplasia type I and cushing\u2019s syndrome due to an aggressive ACTH producing thymic carcinoid","volume":"45","author":"Takagi","year":"2006","journal-title":"Intern Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.07.084","article-title":"ACTH-secreting thymic carcinoid associated with multiple endocrine neoplasia type 1","volume":"81","author":"Yano","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4158\/EP11038.CR","article-title":"Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1","volume":"17","author":"Ghazi","year":"2011","journal-title":"Endocr Pract"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-0141-6","article-title":"Familial cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred","volume":"47","author":"Li","year":"2014","journal-title":"Endocrine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1029041","article-title":"Beyond the \u201c3 ps\u201d: a critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1","volume":"13","author":"Waguespack","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/a-1402-0183","article-title":"Clinical profile and mutations associated with multiple endocrine neoplasia-Type1 (MEN1) and their first-degree relatives at risk of developing MEN1: a prospective study","volume":"53","author":"Shyamasunder","year":"2021","journal-title":"Horm Metab Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3171\/2020.1.JNS193538","article-title":"Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience","volume":"134","author":"Cohen-Cohen","year":"2020","journal-title":"J Neurosurg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-00939-x","article-title":"Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China","volume":"22","author":"Wu","year":"2019","journal-title":"Pituitary"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04220.x","article-title":"Cushing\u2019s syndrome in multiple endocrine neoplasia type 1","volume":"76","author":"Simonds","year":"2012","journal-title":"Clin Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3275\/671610.1007\/BF03346594","article-title":"Prevalence of double pituitary adenomas in a surgical series: clinical, histological and genetic features","volume":"33","author":"Magri","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.93.5.0753","article-title":"Multiple pituitary adenomas in cushing\u2019s disease","volume":"93","author":"Ratliff","year":"2000","journal-title":"J Neurosurg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12022-007-0008-6","article-title":"Complex endocrinopathies in MEN-1: diagnostic dilemmas in endocrine oncology","volume":"18","author":"Al Brahim","year":"2007","journal-title":"Endocr Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-018-9545-4","article-title":"Synchronous multiple pituitary neuroendocrine tumors of different cell lineages","volume":"29","author":"Mete","year":"2018","journal-title":"Endocr Pathol"},{"key":"B19","article-title":"Bilateral pituitary adenomas occurring with multiple endocrine neoplasia type one","volume":"21","author":"Sahdev","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1510709","article-title":"Cushing\u2019s disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1","volume":"151","author":"Rix","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.01943.x","article-title":"Cushing\u2019s disease as the first clinical manifestation of multiple endocrine neoplasia type 1 (MEN1) associated with an R460X mutation of the MEN1 gene","volume":"60","author":"Matsuzaki","year":"2004","journal-title":"Clin Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13796","article-title":"Children with MEN1 gene mutations may present first (and at a young age) with cushing disease","volume":"89","author":"Makri","year":"2018","journal-title":"Clin Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2010.01406.x","article-title":"The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes","volume":"78","author":"Stratakis","year":"2010","journal-title":"Clin Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0075","article-title":"Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas","volume":"185","author":"Martinez de LaPiscina","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1365-2265.2008.03193.x","article-title":"Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation","volume":"69","author":"De Carlo","year":"2008","journal-title":"Clin Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.surg.2021.04.041","article-title":"Multiple endocrine neoplasia type 1 in children and adolescents: clinical features and treatment outcomes","volume":"171","author":"Shariq","year":"2022","journal-title":"Surgery"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1400573","article-title":"Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis","volume":"140","author":"Poncin","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1530\/eje.0.1430047","article-title":"Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism","volume":"143","author":"Miedlich","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"B29","article-title":"Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors","volume":"60","author":"Uchino","year":"2000","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345303","article-title":"Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics","volume":"27","author":"Scarpelli","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346498","article-title":"Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition","volume":"32","author":"Vierimaa","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ng0897-375","article-title":"Somatic mutation of the MEN1 gene in parathyroid tumours","volume":"16","author":"Heppner","year":"1997","journal-title":"Nat Genet"},{"key":"B33","article-title":"Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas","volume":"57","author":"Zhuang","year":"1997","journal-title":"Cancer Res"},{"key":"B34","first-page":"47","article-title":"Multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas in Japan","volume":"14","author":"Kawamura","year":"2005","journal-title":"Oncol Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-006-0124-7","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening","volume":"392","author":"Waldmann","year":"2007","journal-title":"Langenbecks Arch Surg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1530\/EJE-07-0635","article-title":"Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study","volume":"158","author":"Schaefer","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0516","article-title":"The appearance of the adrenal glands on computed tomography in multiple endocrine neoplasia type 1","volume":"159","author":"Whitley","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. analysis of 715 cases from the groupe d\u2019etude des tumeurs endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/jcem.75.1.1352309","article-title":"Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1","volume":"75","author":"Skogseid","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6060(05)80117-5","article-title":"Adrenal lesion in multiple endocrine neoplasia type 1","volume":"118","author":"Skogseid","year":"1995","journal-title":"Surgery"},{"key":"B41","doi-asserted-by":"publisher","first-page":"595","DOI":"10.4158\/EP.14.5.595","article-title":"Diagnosis by serendipity: cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutation","volume":"14","author":"Alzahrani","year":"2008","journal-title":"Endocr Pract"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.111672","article-title":"Hidden diagnosis of multiple endocrine neoplasia-1 unraveled during workup of virilization caused by adrenocortical carcinoma","volume":"17","author":"Kharb","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.1.5388","article-title":"MEN1 gene analysis in sporadic adrenocortical neoplasms","volume":"84","author":"Heppner","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19990129)80:3<373::aid-ijc7>3.0.co;2-b","article-title":"MEN1 gene mutation analysis of sporadic adrenocortical lesions","volume":"80","author":"Gortz","year":"1999","journal-title":"Int J Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s004399900193","article-title":"MEN I gene mutations in sporadic adrenal adenomas","volume":"105","author":"Schulte","year":"1999","journal-title":"Hum Genet"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa017","article-title":"Leptomeningeal metastasis from adrenocortical carcinoma: a case report","volume":"4","author":"Schreiber","year":"2020","journal-title":"J Endocr Soc"},{"key":"B47","article-title":"[Adrenal lesions in patients of multiple endocrine neoplasia type 1]","volume":"90","author":"Zhu","year":"2010","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1210\/clinem\/dgac564","article-title":"Genetic dissection of primary aldosteronism in a patient with MEN1 and ipsilateral adrenocortical carcinoma and adenoma","volume":"108","author":"Parisien-La Salle","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac073","article-title":"The mount Sinai clinical pathway for the diagnosis and management of hypercortisolism due to ectopic ACTH syndrome","volume":"6","author":"Alba","year":"2022","journal-title":"J Endocr Soc"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the national institutes of health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3355","article-title":"Neuroendocrine ACTH-producing tumor of the thymus\u2013experience with 12 patients over 25 years","volume":"97","author":"Neary","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199701000-00002","article-title":"Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1","volume":"76","author":"Teh","year":"1997","journal-title":"Med (Baltimore)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021314","article-title":"Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1","volume":"88","author":"Gibril","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1155","article-title":"Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series","volume":"90","author":"Ferolla","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-016-0269-y","article-title":"Clinical features, treatments, and outcomes of patients with thymic carcinoids and multiple endocrine neoplasia type 1 syndrome at MD Anderson cancer center","volume":"7","author":"Christakis","year":"2016","journal-title":"Hormones Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-9980-y","article-title":"Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des tumeurs endocrines)","volume":"33","author":"Goudet","year":"2009","journal-title":"World J Surg"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. a GTE (Groupe d\u2019Etude des tumeurs endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18590","article-title":"Cushing\u2019s syndrome due to a functional thymic neuroendocrine tumor in multiple endocrine neoplasia type 1 syndrome","volume":"13","author":"Asemota","year":"2021","journal-title":"Cureus"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-013-9692-1","article-title":"Ectopic cushing syndrome associated with thymic carcinoid tumor as the first presentation of MEN1 syndrome-report of a family with MEN1 gene mutation","volume":"13","author":"Hasani-Ranjbar","year":"2014","journal-title":"Fam Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00329.x","article-title":"Thymic carcinoids in multiple endocrine neoplasia type 1","volume":"243","author":"Teh","year":"1998","journal-title":"J Intern Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0262","article-title":"Cyclic cushing\u2019s syndrome: a clinical challenge","volume":"157","author":"Meinardi","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1159\/000526775","article-title":"Revisiting the evidence for routine transcervical thymectomy for the prevention of thymic carcinoid tumours in MEN-1 patients","volume":"100","author":"De Jong","year":"2022","journal-title":"Oncology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1210\/clinem\/dgaa488","article-title":"Ectopic ACTH- and\/or CRH-producing pheochromocytomas","volume":"106","author":"Elliott","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-17-0058","article-title":"A rare case of an ACTH\/CRH co-secreting midgut neuroendocrine tumor mimicking cushing\u2019s disease","volume":"2017","author":"Streuli","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2945","article-title":"Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it","volume":"100","author":"Karageorgiadis","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401514","article-title":"Ectopic cushing\u2019s syndrome due to CRH secreting liver metastasis in a patient with medullary thyroid carcinoma","volume":"7","author":"Chrisoulidou","year":"2008","journal-title":"Hormones (Athens)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199109263251301","article-title":"Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of cushing\u2019s syndrome","volume":"325","author":"Oldfield","year":"1991","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01035-1","article-title":"Optimizing MR imaging for intraoperative image guidance in sellar pathologies","volume":"23","author":"Micko","year":"2020","journal-title":"Pituitary"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0007","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: the role of the desmopressin test in the diagnosis and follow-up of cushing\u2019s syndrome","volume":"178","author":"Vassiliadi","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00185","article-title":"Artificial intelligence and machine learning in endocrinology and metabolism: the dawn of a new era","volume":"10","author":"Gubbi","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3803\/EnM.2020.35.1.71","article-title":"Machine learning applications in endocrinology and metabolism research: an overview","volume":"35","author":"Hong","year":"2020","journal-title":"Endocrinol Metab (Seoul)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1183297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T10:24:51Z","timestamp":1687256691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1183297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":73,"alternative-id":["10.3389\/fendo.2023.1183297"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1183297","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"article-number":"1183297"}}